Background and Purpose-Secreted isoforms of amyloid ␤-protein precursor (A␤PP) that contain the Kunitz proteinase inhibitor domain, also known as protease nexin-2 (PN2), are enriched in brain. Although little is known of its physiological function, the potent inhibition of certain prothrombotic proteinases by PN2/A␤PP suggests that it may function to regulate cerebral thrombosis during vascular injury events. Methods-To examine the antithrombotic function of cerebral PN2/A␤PP in vivo, we performed measurements of carotid artery thrombosis and experimental intracerebral hemorrhage in transgenic mice with specific and modest overexpression of PN2/A␤PP in brain. Comparisons were made with wild-type mice and Tg-rPF4/APP mice, a model that possesses specific and modest overexpression of PN2/A␤PP in platelets and exhibits reduced thrombosis in vivo. Results-Modest overexpression of PN2/A␤PP in transgenic mouse brain had no effect on intraluminal carotid arterial thrombosis but resulted in larger hematoma volumes and hemoglobin levels (23. Conclusions-These findings indicate that cerebral PN2/A␤PP plays a significant role in regulating thrombosis in brain and that modest age-related increases in the cerebral levels of this protein could markedly enhance the extent of cerebral hemorrhage.
T he amyloid ␤-protein precursor (A␤PP) is most often recognized as the parent molecule to the amyloid ␤-protein (A␤) that accumulates in the brains of patients with Alzheimer disease and related disorders. 1 Although much has been elucidated regarding the proteolytic processing of A␤PP involved with liberating A␤, little remains known of A␤PP function. A␤PP is expressed predominantly as 3 isoforms of increasing length (695, 751, and 770 amino acids) with the 2 larger containing a Kunitz proteinase inhibitor (KPI) domain. 1,2 Secreted KPI-containing 751/770 isoforms of A␤PP are analogous to the cell-secreted proteinase-inhibitor known as protease nexin-2 (PN2). 3 PN2/ A␤PP is abundant in brain and its expression increases with age in the cerebral compartment. 2, 4, 5 PN2/A␤PP is a potent inhibitor of several key prothrombotic proteinases. 6, 7 In addition to brain, PN2/A␤PP is abundantly expressed in circulating blood platelets. 8 Recently, we demonstrated that modest overexpression of PN2/A␤PP in the platelets of transgenic mice results in decreased thrombosis in vivo. 9 Although these results support the function of platelet PN2/A␤PP in regulating thrombosis in vivo the potential role of brain PN2/A␤PP in limiting cerebral thrombosis is unclear.
To determine whether elevated cerebral PN2/A␤PP levels in mice are associated with an increased severity in hemorrhage, transgenic mice that specifically and modestly overexpress PN2/A␤PP in brain were quantitatively analyzed in experimental models of carotid artery thrombosis and intracerebral hemorrhage and were compared with transgenic mice that modestly overexpress PN2/A␤PP in platelets and wild-type mice.
Materials and Methods

Transgenic Mice
All work with animals followed National Institutes of Health guidelines and was approved by the Stony Brook University Institutional Animal Care and Use Committee. The generation and characterization of transgenic mice specifically expressing PN2/ A␤PP either in platelets under control of the rat platelet factor 4 promoter (Tg-rPF4/APP) or in neurons in brain under control of the mouse Thy1 promoter (Tg-Thy1/APP) were recently described. 9, 10 In all experiments transgenic and wild-type mice were 3 months of age and all on a pure C57Bl/6 background.
Quantitative Immunoblot Analysis for PN2/A␤PP
The levels of human PN2/A␤PP and total PN2/A␤PP (mouseϩhuman) in isolated mouse platelet or forebrain homogenates were determined by quantitative immunoblotting using monoclonal antibody (mAb) P2-1 that is specific for human A␤PP or mAb 22C11 that recognizes both human and mouse A␤PP as described. 9, 10 
Carotid Artery Thrombosis
This technique was performed according to the protocol of Eitzman et al 11 as recently described. 9
Experimental Intracerebral Hemorrhage
This procedure was performed according to the protocol of Clark et al. 12 Briefly, 500 nL of bacterial collagenase/saline (150 U/mL) was stereotaxically delivered to the caudate/putamen at a depth of 4.0 mm unilaterally to promote collagen degradation leading to vessel rupture. Eighteen hours after initiation of hemorrhage the mice were perfused with PBS, the brains were harvested and then analyzed for hematoma volumes as described. 9 Alternatively, harvested perfused brains were divided midline sagitally and the hemoglobin levels were determined in the hemorrhage and contralateral hemispheres using a spectrophotometric assay as a measure of the extent of hemorrhage in the lesioned hemispheres of the mice. 13 
Statistical Analysis
Comparison of results obtained from transgenic mice and wild-type mice were analyzed by 1-way ANOVA between the groups followed by post-hoc pair-wise Tukey-Kramer tests at the 0.05 significance level using GB-Stat 6.5 software.
Results
Analysis of transgene-encoded human PN2/A␤PP expression in the different transgenic lines confirmed that the protein is specifically expressed in platelets in the Tg-rPF4/APP mice ( Figure 1A ) and in brain in the Tg-Thy1/APP mice ( Figure  1D ). Quantitation of PN2/A␤PP expression in each transgenic line showed a comparable modest level of overexpression of the protein that only approximately doubled the amount of PN2/A␤PP in platelets in the Tg-rPF4/APP mice ( Figure 1B and 1C ) or in brain in the Tg-Thy1/APP mice ( Figure 1E and 1F) .
To determine the effect of modest brain parenchymal increases in PN2/A␤PP on intraluminal arterial thrombosis we performed a quantitative carotid artery thrombosis procedure in Tg-Thy1/APP mice. In all experiments, Tg-rPF4/APP homogenates prepared from the different mice using mAbP2-1 that is specific for human A␤PP. PN2/A␤PP is expressed only in platelets of Tg-rPF4/APP mice or brain of Tg-Thy1/APP mice. Immunoblot analysis of total (mouseϩhuman) PN2/A␤PP in platelet (B) or brain (E) homogenates prepared from different mice using mAb22C11 that recognizes both human and mouse A␤PP. Quantitation of increased PN2/A␤PP levels in platelet (C) or brain (F) homogenates prepared from the different mice. Data shown are meanϮSD (nϭ5); *PϽ0.01.
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mice were also included because we have recently shown that they exhibit reduced thrombosis in vivo. 9 In contrast to Tg-rPF4/APP mice, the Tg-Thy1/APP mice exhibited no effect and were indistinguishable from wild-type mice in the time to vessel occlusion and cessation of blood flow ( Figure  2 ). This indicates that modestly elevated PN2/A␤PP levels in the brain parenchyma do not influence thrombosis occurring within the lumen of an intact vessel of Tg-Thy1/APP mice. We next determined the effect of increased brain parenchymal PN2/A␤PP levels on the severity of experimental intracerebral hemorrhage. In this case, the hematoma volumes were significantly larger (PϽ0.01) in both Tg-Thy1/APP mice (23.1Ϯ2.7 mm (Figure 3A through  3D) . Similarly, the hemoglobin content of the hemorrhagic brain hemispheres was significantly higher in Tg-Thy1/APP mice (1411Ϯ202 g/hemisphere, PϽ0.01) and Tg-rPF4/APP mice (1830Ϯ306 g/hemisphere, PϽ0.01) compared with wild-type mice (946Ϯ418 g/hemisphere) as an independent measure of hemorrhage severity ( Figure 3E ). This finding indicates that when cerebral vessel rupture occurs modest increases in brain parenchymal PN2/A␤PP can significantly reduce thrombosis and increase the severity of hemorrhage.
Discussion
In the present study, we show that the Tg-Thy1/APP mouse is a useful model to investigate the effects of modestly increased brain PN2/A␤PP levels in regulating thrombosis during cerebral vascular injury. Cerebral PN2/A␤PP levels are reported to increase with age and after brain injury. 4, 5, 14, 15 Increased brain parenchymal PN2/A␤PP had no effect on carotid artery thrombosis because it is inaccessible to prothrombotic mediators that are activated in the intact vessel lumen. On the other hand, with vessel rupture during experimental intracerebral hemorrhage extravasated prothrombotic proteinases are now exposed to both cellular and secreted PN2/A␤PP in the brain parenchyma resulting in inhibition and more extensive bleeding. A␤ peptide, the amyloidogenic fragment of A␤PP, can affect cerebral blood flow. 16 Although we have not been able to detect A␤ in Tg-rPF4/APP mice, Tg-Thy1/APP mice show very small amounts of soluble A␤ in brain parenchyma. 10 Whether this would have an effect on cerebral blood flow during experimental hemorrhage is presently unknown. The findings in this study suggest that small increases in brain PN2/A␤PP levels can have a significant impact on cerebral thrombosis and are consistent with ageand disease-related increases of this protein in brain that may contribute to the severity of hemorrhage.
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